Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

Robert Stuver, Gunjan L. Shah, Neha S. Korde, Lindsey E. Roeker, Anthony R. Mato, Connie L. Batlevi, David J. Chung, Sital Doddi, Lorenzo Falchi, Boglarka Gyurkocza, Audrey Hamilton, Ya Hui Lin, Ann A. Jakubowski, Erel Joffe, Heather L. Landau, Richard J. Lin, Sham Mailankody, M. Lia Palomba, Jae H. Park, Miguel Angel PeralesDoris M. Ponce, Lakshmi V. Ramanathan, Gilles A. Salles, Michael Scordo, Susan K. Seo, Urvi A. Shah, Eytan M. Stein, David Straus, Saad Z. Usmani, James W. Young, Andrew D. Zelenetz, Ariela Noy, Santosha A. Vardhana

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)590-591
Number of pages2
JournalCancer Cell
Volume40
Issue number6
DOIs
StatePublished - 13 Jun 2022
Externally publishedYes

Cite this